READ-IT

  • Learning and Monitoring Zone

Search

  • Home
  • About READ-It
    • READ-It Partners
    • Key achievements
    • READ-It impact posters
    • READ-It Management Office
  • Publications & Multimedia
    • READ-It annual reports
    • Resources
    • Guidelines
    • Multimedia resources
    • Other publications and stories
  • Cochrane reviews
    • Cochrane Reviews: COVID-19
    • Cochrane Reviews: Other topics
    • Cochrane Reviews: Maternal and child health
    • Cochrane Reviews: Neglected tropical diseases
    • Cochrane Reviews: HIV/AIDS
    • Cochrane Reviews: Tuberculosis
    • Cochrane Reviews: Diarrhoea
    • Cochrane Reviews: Malaria
  • News & Events
HomeCochrane reviewsCochrane Reviews: Tuberculosis

Cochrane Reviews on tuberculosis by the READ-It team

Cochrane Reviews: Tuberculosis

0
28 Aug 2019

Contact tracing strategies in household and congregate environments to identify cases of tuberculosis in low‐ and moderate‐incidence populations

To assess the effectiveness of novel methods of contact tracing versus current standard of care to identify latent and active cases in low‐ to moderate‐incidence settings.

Cochrane Systematic Review: NEW
07 Jun 2019

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults

To determine the diagnostic accuracy of Xpert MTB/RIF and Xpert Ultra for tuberculosis in adults with presumptive PTB, and for rifampicin resistance in adults with presumptive rifampicin‐resistant tuberculosis or MDR‐TB.

 

Cochrane Systematic Review: UPDATE
30 Apr 2019

MVA85A vaccine to enhance BCG for preventing tuberculosis

The aim of this Cochrane review was to evaluate the effectiveness and safety of using MVA85A in addition to BCG compared to using BCG alone for the prevention of tuberculosis.

Cochrane Systematic Review: NEW
20 Mar 2019

Linezolid for drug‐resistant pulmonary tuberculosis

Recent international guidelines recommend trying to include linezolid in the treatment of all patients with multi‐drug resistant tuberculosis, but there is concern about whether enough good evidence exists to tell us how well it works, what dose is best, and how safe it is for people who take it.

Cochrane Systematic Review: NEW
  • ‹ previous
  • 5 of 6
  • next ›

Follow us

  • Facebook
  • Twitter

READ-It (project number 300342-104) is funded by the Foreign, Commonwealth and Development Office (FCDO)

  • Privacy
  • Disclaimer
A Remora website by Manta Ray Media